We collected data from the TCGA database of cancer and normal samples to investigated whether breast cancer patients had aberrant circulating level of GOLPH3.We found that breast cancer patients (n = 1097) showed higher level of GOLPH3 compared with normal tissue (Fig. 1a). This evidence concerns the gene GOLPH3 and breast cancer.